Protara Therapeutics (TARA) Shares Repurchased (2021 - 2026)

Protara Therapeutics' Shares Repurchased history runs 6 years deep, the most recent figure standing at $317000.0 for Q1 2026.

• In Q1 2026, Shares Repurchased rose 161.98% year-over-year to $317000.0; the TTM figure through Mar 2026 stood at $881000.0 (up 95.78% YoY), while the FY2025 annual figure was $685000.0, up 42.71% from the prior year.
• Shares Repurchased was $317000.0 for Q1 2026 at Protara Therapeutics, up from $201000.0 in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $1.1 million in Q4 2023 to a low of $18000.0 in Q3 2022.
• Historically, Shares Repurchased has averaged $240266.7 across 5 years, with a median of $167000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Shares Repurchased jumped 1427.78% in 2023, then tumbled 90.24% in 2024.
• A 5-year view of Shares Repurchased shows it stood at $18000.0 in 2022, then soared by 6105.56% to $1.1 million in 2023, then sank by 90.24% to $109000.0 in 2024, then jumped by 84.4% to $201000.0 in 2025, then jumped by 57.71% to $317000.0 in 2026.
• The last three Shares Repurchased figures came in at $317000.0 (Q1 2026), $201000.0 (Q4 2025), and $196000.0 (Q3 2025), per Business Quant data.